According to OSE Immunotherapeutics's latest financial reports the company's current earnings (TTM) are -ยฃ19.56 M. In 2023 the company made an earning of -ยฃ19.56 M a decrease over its 2022 earnings that were of -ยฃ14.74 M.The earnings displayed on this page is the company's Pretax Income.